Aten Therapeutics Ltd
SC547221 · Active
Company details
- Type
- Private Limited Company
- Incorporated
- 2016-10-07
- Country of origin
- United Kingdom
Accounts & filings
- Accounts last filed
- 2024-09-30 · TOTAL EXEMPTION FULL
- Next accounts due
- 2026-06-30 due in 22 days
- Confirmation statement
- last made up 2025-10-16 · next due 2026-10-30
Registered office
1 Lochrin Square92-98 Fountainbridge
Edinburgh
Eh3 9qa
Financial health
Derived from the filed accounts to Sep 2024. Figures only — not advice.
See this company's financial health
£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.
Based on this company's latest filed accounts (to Sep 2024) · Balance sheet only — small-company filing, no public profit & loss.
Unlock for £1Ratios and signals derived from this company's filed Companies House figures only.
Accounts
Based on this company's latest filed accounts (to Sep 2024) · Balance sheet only — small-company filing, no public profit & loss.
| Year ending | Sep 2024 | Sep 2023 | Sep 2022 | Oct 2021 | Oct 2020 |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Current assets |
£5,320
↓84.5%
|
£34,409
↓41.0%
|
£58,296
↑5829500.0%
|
£1
|
— |
| Cash |
£433
↓98.4%
|
£27,376
↓34.6%
|
£41,886
|
£0
|
— |
| Debtors |
£4,887
↓30.5%
|
£7,033
↓57.1%
|
£16,410
↑1640900.0%
|
£1
|
— |
| Net current assets |
£-128,463
↑11.8%
|
£-145,651
↓215.3%
|
£-46,188
|
£1
|
— |
| Net assets | — |
— |
— |
£1
→0.0%
|
£1
|
| Equity |
£-128,463
↑11.8%
|
£-145,651
↓215.3%
|
£-46,188
|
£1
→0.0%
|
£1
|
| Other | |||||
| Average employees |
0
|
0
|
0
|
0
|
— |
Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.
Industry (SIC codes)
Officers (3)
- Abercrombie, Ian · Director appointed 2022-02-02
- Hanna, Wilfred Sydney · Director appointed 2019-10-01
- Quinn, Martin Alexander · Director appointed 2016-10-07 resigned 2019-10-01
People with significant control (2)
-
Mr Martin Alexander Quinn Ceased 2019-10-01Individual Psc · British · resident in United Kingdom · born 3/1970 · notified 2016-10-07Ownership of shares 75 to 100 percent
-
Oncobiopharm Limited ActiveCorporate Entity Psc · notified 2019-10-01Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent
Recent filings (15)
- 2025-10-24 Confirmation statement (no updates) CS01 Confirmation statement
- 2025-06-23 Total-exemption-full accounts AA Accounts
- 2024-11-28 Confirmation statement (no updates) CS01 Confirmation statement
- 2024-06-25 Total-exemption-full accounts AA Accounts
- 2023-10-18 Confirmation statement (no updates) CS01 Confirmation statement
- 2023-06-30 Small-company accounts AA Accounts
- 2022-10-17 Confirmation statement (no updates) CS01 Confirmation statement
- 2022-08-03 Change account reference date company current shortened AA01 Accounts
- 2022-07-27 Dormant accounts AA Accounts
- 2022-02-15 Appointment of director AP01 Officers
- 2021-10-26 Confirmation statement (with updates) CS01 Confirmation statement
- 2021-07-27 Dormant accounts AA Accounts
- 2020-10-16 Confirmation statement (no updates) CS01 Confirmation statement
- 2020-10-16 Change to a person with significant control PSC05 PSC
- 2020-05-13 Dormant accounts AA Accounts
Showing the 15 most recent filings. View full filing history at Companies House.
Source: Companies House register